Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2022-03, Vol.165, p.S46
Main Authors: Osborne, Lucy, Ortega-Franco, Ana, Hodgson, Clare, Pearce, Mark, Moss, Anna, Lindsay, Colin, Hughes, Sarah, Taylor, Paul, Califano, Raffaele, Rafee, Shereen, Gomes, Fabio, Summers, Yvonne, Blackhall, Fiona, Cove-Smith, Laura, Halkyard, Emma, Fenemore, Jackie
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0169-5002
DOI:10.1016/S0169-5002(22)00144-1